Endocrinology Search
Endocrinology Endocrinology
obesity
OBESITY
Obesity is having an excessive amount of body fat in relation to lean body mass that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include to lose 5-10% of body weight or 0.5-1 kg (1-2 lb)/week for 6 months and regain of <3 kg in 2 years and sustained reduction of waist circumference of at least 4 cm.
Strategies are aiming for realistic goals and a multidisciplinary approach that is a combination of dietary change, physical activity and behavioral modification.
Drug Information

Indication: In conjunction w/ a calorie-restricted diet for obesity in patient w/ BMI ≥30 kg/m2 w/ other ris...

Indication: Adjunctive therapy to diet in patients w/ obesity & BMI ≥30, who have not responded to an appropriate w...

Indication: Short-term adjunct in the management of obesity in a medically monitored comprehensive regimen of wt reduction...

Indication: Iin conjunction w/ a mildly hypocaloric diet for obese (BMI ≥30 kg/m2) & overwt (BMI ≥28 ...

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
NIH, IMU collaboration to boost research, have health impact on Malaysians
Saras Ramiya, 10 Aug 2018
The National Institutes of Health (NIH) and International Medical University (IMU) strengthens their research collaboration with the recent signing of a Memorandum of Understanding (MoU).
Hypertension during pregnancy may impact CV health for life
Pearl Toh, 20 Jul 2018
Women with pre-eclampsia or gestational hypertension during their first pregnancy had an increased risk of developing chronic hypertension, type 2 diabetes (T2D), and hypercholesterolaemia than those who were normotensive during pregnancy, according to a study. The risk persisted for several decades later, signalling these hypertensive disorders of pregnancy (HDP) as red flags for cardiovascular (CV) health for life.
Canagliflozin may protect kidney function in T2D
Roshini Claire Anthony, 30 Jul 2018

Canagliflozin may provide a renoprotective effect in individuals with type 2 diabetes (T2D) and a history of cardiovascular disease (CVD), according to results from the CANVAS* Program.
Metformin shows anti-TB effect in patients with type 2 diabetes
Jairia Dela Cruz, 13 Aug 2018
Treatment with metformin appears to significantly reduce tuberculosis (TB) risk in patients with type 2 diabetes mellitus, a study has found. However, this protective effect diminishes with age and is absent among those with metabolic disorders.